Report Type : Therapy Reports

Report Category : Gastrointestinal

Report Subcategory : Ulcerative Colitis

Price : 2999.00

Date : March 2023

Ulcerative Colitis : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Ulcerative colitis (UC):
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes ulcers and inflammation in the colon and rectum. It's the most common form of inflammatory bowel disease (IBD).

• Etiology
  The exact cause of UC is unknown, but it's likely a combination of genetic and environmental factors. Some risk factors include: 
  • Family history: A family history of UC increases the risk of developing the disease. 
  • Drugs: Oral contraceptives, hormone replacement therapy, and non-steroidal anti-inflammatory drugs can increase the risk of UC. 
  • Appendectomy: An appendectomy, especially for acute appendicitis in young patients, appears to protect against developing UC. 
  • Breastfeeding: Breastfeeding appears to decrease the risk of UC. 
  • Urban living: Urban living can increase the risk of UC. 
• Incidence
  The incidence of UC varies by location, but the overall incidence is reported as 1.2 to 20.3 cases per 100,000 people per year. Incidence rates are highest in North America and Western Europe, and lowest in the southern hemisphere and eastern countries. 
• Prevalence
  The prevalence of UC varies by location, but the overall prevalence is reported as 7.6 to 245 cases per 100,000 people per year. Prevalence rates are highest in North America and Western Europe, and lowest in the southern hemisphere and eastern countries. 
• Age
  UC has a bimodal pattern of incidence, with the main peak between ages 15 and 30 years, and a second smaller peak between ages 50 and 70 year

1. Johnson & Johnson
2. F. Hoffmann-La Roche Ltd
3. Pfizer Inc
4. Novartis AG
5. Merck & Co Inc
6. GlaxoSmithKline Plc
7. Sanofi
8. Mitsubishi Chemical Holdings Corp
9. AbbVie Inc
10. Takeda Pharmaceutical Co Ltd
11. Bristol-Myers Squibb Co
12. AstraZeneca Plc
13. Amgen Inc
14. Gilead Sciences Inc
15. Eli Lilly and Co
16. Boehringer Ingelheim International GmbH
17. Teva Pharmaceutical Industries Ltd
18. Biogen Inc
19. Astellas Pharma Inc
20. Mylan NV
21. Bausch Health Companies Inc
22. Eisai Co Ltd
23. UCB SA
24. EBOS Group Ltd
25. Sino Biopharmaceutical Ltd
26. Mitsubishi Tanabe Pharma Corp
27. Shionogi & Co Ltd
28. Aspen Pharmacare Holdings Ltd
29. Endo International Plc
30. Humanwell Healthcare Group Co Ltd
31. Cipla Ltd
32. Cadila Healthcare Ltd
33. Vifor Pharma Ltd
34. Swedish Orphan Biovitrum AB
35. Glenmark Pharmaceuticals Ltd
36. Yuhan Corp
37. Torrent Pharmaceuticals Ltd
38. Daewoong Co Ltd
39. Alkem Laboratories Ltd
40. Mochida Pharmaceutical Co Ltd
41. Celltrion Inc
42. Esteve Pharmaceuticals SA
43. Chong Kun Dang Pharmaceutical Corp
44. Kaken Pharmaceutical Co Ltd
45. Zeria Pharmaceutical Co Ltd
46. Galapagos NV
47. Akebia Therapeutics Inc
48. Lexicon Pharmaceuticals Inc
49. GW Pharmaceuticals Plc
50. Theravance Biopharma Inc